Search form



CL Mobile Menu

Payal Kohli, MD

Payal Kohli, MD

Dr Kohli is a graduate of Harvard Medical School, where she received a magna cum laude distinction. She completed a residency in Internal Medicine at Harvard Medical School/Brigham & Women’s hospital and a fellowship in cardiovascular diseases at the University of California San Francisco. Currently she is in practice with a cardiovascular medicine group in Denver, Colorado.




Posts by Author

In these complicated patients, should warfarin or a novel oral anticoagulant be chosen for stroke prevention?

Is aspirin safe as antithrombotic therapy in pregnancy? Is electrocardioversion first-line treatment? Get the answers and other reminders, here.

Answers to 5 simple questions about your patient and the pending procedure create a pathway to decisions about perioperative anticoagulation.

A study from Spain identified causes of residual death in patients with AF on anticoagulation. The results may come as a surprise.


Implantable cardiac monitoring devices now detect "silent" AF. But now that we "hear" it, what should we do?


A signal for increased risk of hemorrhage when the NOAC is coadministered with 2 statins comes as a surprise to some.

Tachy-brady syndrome can be a particular management challenge in an elderly patient. How would you manage Mrs Robertson?

Concurrence of AF and SSS is common in older patients and presents a treatment conundrum. Can you balance safety and efficacy in this patient?

Which antiarrhythmic agent would you choose for first-episode atrial fibrillation in a patient with congestive heart failure, and why?

Could triple therapy after TAVR in patients with AF and on warfarin be one therapy too many? Results reported at ESC, here.


By clicking Accept, you agree to become a member of the UBM Medica Community.